P

Inventor

YASUDA NOBUYOSHI

US66 patents
⚠️ This page may combine multiple inventors who share the name “YASUDA NOBUYOSHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

17 patents
US5633405AMay 27, 1997

Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one

MERCK & CO INC21 citations92
US6407241B1Jun 18, 2002

Process and intermediates for the preparation of imidazolidinone αv integrin antagonists

MERCK & CO INC19 citations82
US7301026B2Nov 27, 2007

Process for making fluorinated 4-azasteroid derivatives

MERCK & CO INC10 citations80
US5338875AAug 16, 1994

Boron containing intermediates useful in the preparation of carbapenems

MERCK & CO INC19 citations79
US5698741ADec 16, 1997

Asymmetric synthesis of (-)6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one

MERCK & CO INC5 citations74
US7074930B2Jul 11, 2006

Amine salts of an integrin receptor antagonist

MERCK & CO INC10 citations73
US5434152AJul 18, 1995

Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone

MERCK & CO INC13 citations73
US6706885B2Mar 16, 2004

Process for preparing integrin antagonist intermediates

MERCK & CO INC2 citations62
US6262268B1Jul 17, 2001

Process and intermediates to a tetrahydro-[1,8]-naphthyridine

MERCK & CO INC4 citations62
US5783709AJul 21, 1998

Stereoselective process for making substituted amino acid derivatives

MERCK & CO INC2 citations62
US5457201AOct 10, 1995

Chiral resolution process

MERCK & CO INC4 citations62
US6646130B2Nov 11, 2003

Process to chiral integrin antagonist beta-amino acid intermediate

MERCK & CO INC2 citations61
US6423845B1Jul 23, 2002

Process and intermediates to a tetrahydro-[1,8]- Naphthyridine

MERCK & CO INC4 citations61
US6048978AApr 11, 2000

Process for the synthesis of carbapenem intermediates, and compounds produced

MERCK & CO INC2 citations61
US6346617B1Feb 12, 2002

Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof

MERCK & CO INC3 citations60
US5426230AJun 20, 1995

Process for the preparation of 4-chloro-2-cyclopropylcarbonylaniline

MERCK & CO INC4 citations60
US6080854AJun 27, 2000

Process for synthesizing carbapenem intermediates

MERCK & CO INC4 citations58

MERCK SHARP & DOHME

15 patents
US9822121B2Nov 21, 2017

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME13 citations92
US10106541B2Oct 23, 2018

Intermediates for preparing CGRP receptor antagonists

MERCK SHARP & DOHME16 citations91
US9850246B2Dec 26, 2017

Process for making CGRP receptor antagonists

MERCK SHARP & DOHME17 citations91
US9174989B2Nov 3, 2015

Process for making CGRP receptor antagonists

MERCK SHARP & DOHME19 citations91
US11708371B2Jul 25, 2023

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME3 citations83
US11124478B2Sep 21, 2021

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME5 citations83
US10899771B2Jan 26, 2021

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME7 citations83
US10577316B2Mar 3, 2020

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME9 citations83
US10435410B2Oct 8, 2019

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME9 citations83
US10087189B2Oct 2, 2018

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME10 citations83
US9809536B2Nov 7, 2017

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME12 citations83
US9376431B2Jun 28, 2016

Bis-quaternary cinchona alkaloid salts as asymmetric phase transfer catalysts

MERCK SHARP & DOHME16 citations82
US9487523B2Nov 8, 2016

Process for making CGRP receptor antagonists

MERCK SHARP & DOHME17 citations81
US11767292B2Sep 26, 2023

Process for making beta 3 agonists and intermediates

MERCK SHARP & DOHME3 citations72
US9604985B2Mar 28, 2017

Process for the preparation of chiral tert-butyl 4-((1R,2S,5R)-6(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carb derivatives and (2S,5R)-7-oxo-N-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide

MERCK SHARP & DOHME3 citations72

FUJISAWA PHARMACEUTICAL CO

11 patents

KURASHIKI BOSEKI KK

4 patents

(unassigned)

2 patents

YASUDA NOBUYOSHI

1 patent

Showing the top 50 of 66 patents by PatentIndex Score.